coronavirus-infections

Documents about coronavirus-infections

• Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19#830566ClinicalTrials.gov
• Data protection during the coronavirus crisis#465602OpenAlex
• Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community#801539ClinicalTrials.gov
• MERS situation update: May 2021#435423WHO IRIS
• How US law will evaluate artificial intelligence for covid-19#964484OpenAlex
• Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial#1009680ClinicalTrials.gov
• French COVID Cohort#1031234ClinicalTrials.gov
• Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a#832748ClinicalTrials.gov
• Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil#67666ClinicalTrials.gov
• Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis#481125OpenAlex
• Stellate Ganglion Block for COVID-induced Parosmia#914898ClinicalTrials.gov
• Longitudinal serum proteomics analyses reveal biomarkers for porcine influenza and coronavirus infections#216635bioRxiv / medRxiv
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age#890407ClinicalTrials.gov
• Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19#969864ClinicalTrials.gov
• Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses#876921ClinicalTrials.gov
• Longitudinal serum proteomics analyses reveal discriminatory biomarkers for influenza and coronavirus infections#370406Europe PMC
• COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir#991911ClinicalTrials.gov
• Informe no 55. Situación de COVID-19 en España. Casos diagnosticados a partir 10 de mayo#646718Repisalud
• Will Hydroxychloroquine Impede or Prevent COVID-19#834559ClinicalTrials.gov
• A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir#879497ClinicalTrials.gov
• A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)#872184ClinicalTrials.gov
• Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine#441967ClinicalTrials.gov
• Prospective Monitoring of BNT162b2 Second Vaccination Booster Effects in Health Care Workers (HCW)#848031ClinicalTrials.gov
• Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.#812374ClinicalTrials.gov
• Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19#902913ClinicalTrials.gov
• Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 13 January 2023#413789WHO IRIS
• Outcomes of Patients With COVID-19 in the Intensive Care Unit#841625ClinicalTrials.gov
• COVID-19 monthly update: April 2021#435422WHO IRIS
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease#978924ClinicalTrials.gov
• How to conduct surveillance and investigations of human infection with Middle East respiratory syndrome coronavirus using WHO’s investigations and studies (unity studies 2.0) protocols: protocol, tools and implementation guidance#267425WHO IRIS
• Colchicine Counteracting Inflammation in COVID-19 Pneumonia#891732ClinicalTrials.gov
• Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.#917368ClinicalTrials.gov
• Efficacy of Ivermectin in Outpatients With Non-severe COVID-19#993527ClinicalTrials.gov
• COVID-19 in Immunosuppressed Children#805950ClinicalTrials.gov
• Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)#828626ClinicalTrials.gov
• A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations#903646ClinicalTrials.gov
• An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)#174949ClinicalTrials.gov
• Cuidado de enfermagem às pessoas com feridas crônicas na atenção básica no contexto da Covid-19#236657Repositório Institucional da UFPB
• Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data#295577OpenAlex
• WHO guidelines on the use of chest imaging in COVID-19#404869WHO IRIS
• Acute Respiratory Failure and COVID-19 in Real Life#870400ClinicalTrials.gov
• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised#904272ClinicalTrials.gov
• Covid-19 and Diabetes in West of Algeria#300353ClinicalTrials.gov
• Repurposing facilities for quarantine or isolation and management of mild COVID-19 cases#649878WHO IRIS
• COVID-19 infection prevention and control living guideline: mask use in community settings, 22 December 2021#413792WHO IRIS
• The Respiratory Protection Effectiveness Clinical Trial#804899ClinicalTrials.gov
• Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)#859205ClinicalTrials.gov
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)#67717ClinicalTrials.gov
• Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection#894611ClinicalTrials.gov
• Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID#969451ClinicalTrials.gov